Bioequivalence of levofloxacin hydrochloride oral liquid in healthy volunteers
Xiaohui Di
Abstract
Xiaohui Di
Abstract
Objective To study the relative bioavailability of levofloxacin hydrochloride oral liquid and tablets in healthy volunteers. Methods In a randomized two- way crossover design,a single oral dose of 200mg levofloxacin hydrochloride oral liquid and tablets were given to 24 male healthy volunteers.The plasma levofloxacin concentration within 36 h after administration was determined by HPLC and parameters C_(max),T_(max),T_(1/2),AUC_((0-1)),AUC_((0-∞)) were obtained and analyzed by two- one side test.Results The C_(max) were(2.80±0.59) and(2.64±0.56)μg /ml,respectively;T_(max) were(0.66±0.18 ) and(0.82±0.34) h,respectively;T_(1/2) were (6.60±1.37)and(7.26±1.20) h,respectively;AUC_((0-t)) were(14.97±2.32)μg.h/ml和(15.04±2.32)μg·h/ml,AUC_((0-∞)) were(15.66±2.38 ) and(15.92±2.35 )μg.main pharmacokinetic parameters of levofloxacin hydrochloride oral liquid and tablets were as follows:C_(max) was(2.80±0.59) and(2.64±0.56)μg/ml,respectively;T_(max) was(0.66±0.18) and(0.82±0.34) h,respectively; T_(1/2) was(6.60±1.37) and(7.26±1.20) h,respectively;AUC_((0-t)) was(14.97±2.32)μg·h/ml and(15.04±2.32)μg·h/ml,respectively.AUC_((0-∞)) was(15.66±2.38) and(15.92±2.35)μg·h/ml,respectively.There was no statistically significant difference between these two test groups.The relative bioavailability of the test oral liquid was(100.1±10.6)%.Conclusions The levofloxacin hydrochloride oral liquid and tablets are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the relative bioavailability of levofloxacin hydrochloride oral liquid and tablets in healthy volunteers. Methods In a randomized two- way crossover design,a single oral dose of 200mg levofloxacin hydrochloride oral liquid and tablets were given to 24 male healthy volunteers.The plasma levofloxacin concentration within 36 h after administration was determined by HPLC and parameters C_(max),T_(max),T_(1/2),AUC_((0-1)),AUC_((0-∞)) were obtained and analyzed by two- one side test.Results The C_(max) were(2.80±0.59) and(2.64±0.56)μg /ml,respectively;T_(max) were(0.66±0.18 ) and(0.82±0.34) h,respectively;T_(1/2) were (6.60±1.37)and(7.26±1.20) h,respectively;AUC_((0-t)) were(14.97±2.32)μg.h/ml和(15.04±2.32)μg·h/ml,AUC_((0-∞)) were(15.66±2.38 ) and(15.92±2.35 )μg.main pharmacokinetic parameters of levofloxacin hydrochloride oral liquid and tablets were as follows:C_(max) was(2.80±0.59) and(2.64±0.56)μg/ml,respectively;T_(max) was(0.66±0.18) and(0.82±0.34) h,respectively; T_(1/2) was(6.60±1.37) and(7.26±1.20) h,respectively;AUC_((0-t)) was(14.97±2.32)μg·h/ml and(15.04±2.32)μg·h/ml,respectively.AUC_((0-∞)) was(15.66±2.38) and(15.92±2.35)μg·h/ml,respectively.There was no statistically significant difference between these two test groups.The relative bioavailability of the test oral liquid was(100.1±10.6)%.Conclusions The levofloxacin hydrochloride oral liquid and tablets are bioequivalent.
Key concepts: Bioequivalence, Levofloxacin, Bioavailability, Pharmacokinetics, High-performance liquid chromatography, Hydrochloride, Crossover study, Oral administration